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We present a case of disseminated coccidioidomycosis with formation of a prostatic abscess in a 28-year-
old diabetic male. Though rare, Coccidiodes prostatitis should be included in the differential for patients
who have spent time in endemic areas and present with prostatitis or other genitourinary tract symp-
toms, especially in the setting of immunocompromise. The small number of Coccidiodes prostatitis cases
described in the literature previously are reviewed, along with a wider discussion of coccidioidomycosis.
Treatment modalities for this challenging fungal disease are also discussed.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The incidence of both pulmonary and disseminated Coccidioides
has been rising in areas of high prevalence, attributed to the rising
number of older, HIV, and diabetic patients. Coccidioides, especially
in the setting of immunocompromise, may invade nearly any body
system. Though rare, coccidioidomycosis should be on the differ-
ential for patients presenting with genitourinary complaints in
endemic areas, as it may be the presenting symptom of dissemi-
nated disease.Case presentation
A twenty-eight-year-old male with insulin-dependent diabetes
mellitus presented to an ED in the California San Joaquin Valley
with a yearlong history of progressively worsening urinary incon-
tinence and dysuria. He also complained of worsening shortness of
breath.
Physical examination revealed cachexia. There was suprapubic
tenderness, as well as diffuse lung crackles and decreased breath
sounds on the right. Blood pressure was 150/91, pulse was 84,
temperature 97.5, and respiratory rate was 16.ant from funding agencies in
Inc. This is an open access article uUrinalysis revealedwhite blood cells, large amounts of leukocyte
esterase, blood, and 10,000 mg/dL of glucose. The patient was
admitted to the Intensive Care Unit due to concern over his respi-
ratory status.
Chest CT scan showed multiple bilateral densities and nodules,
along with a large consolidated cavitated mass occupying all three
lobes of the right lung (Fig. 1).
Abdominal CT showed bilateral hydroureteronephrosis with a
large ﬂuid collection at the bladder base that was suspicious for an
abscess causing post-renal obstructive nephropathy (Fig. 2).
Urology and infectious disease were consulted. A bron-
choalveolar lavage and urine culture grew Coccidioides immitus.
Coccidioidal serology was reactive for both IgG and IgM, and the
complement ﬁxation titer was 1:128.
What was determined to be a severe disseminated coccidioidal
infection was treated with intravenous amphotericin B. Urology
consult recommended CT-guided drainage of the prostatic abscess.
The drained pus cultured C. immitis.Discussion
First described in 1888 in an Argentine soldier and shortly
thereafter in two farmers in the San Joaquin Valley, coccidioido-
mycosis is a systemic fungal disease endemic to the Southwestern
United States and Northern Mexico.1 It is caused by C. immitis and
Coccidioides posadasii, the former of which is found in California and
the latter outside of California, though these species displaynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Coronal CT chest showing bilateral lung densities and nodules along with
right lung consolidation.
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identical clinical presentations.1
Approximately 150,000 cases of coccidioidomycosis are docu-
mented annually in the United States.2 97% of cases reported to the
CDC from 1997 and 2011 were from Arizona and California alone.3
Infection is transmitted almost exclusively through inhalation of
arthroconidia (fungal spores). Person-to-person transfer is
extremely uncommon.1
The majority of cases are subclinical. Pulmonary manifestations
are the most common ﬁnding in coccidioidomycosis, and may
include pleural effusions, cavitations, acute respiratory distress
syndrome (ARDS), and sepsis.2 Deﬁnitive diagnosis is based on
culture and histology from respiratory collections. Visualization of
spherules, the pathognomonic ﬁnding for identifying the organism,
is diagnostic of coccidioidomycosis.1
Infection with C. immitis results in symptomatic pulmonary
disease in fewer than half of those infected, and dissemination
beyond the lungs occurs in less than 1% of patients.4e7 At increased
risk for disseminated infection are the immunosuppressed, preg-
nant women, diabetics, and non-Caucasians.4 Filipinos have
repeatedly been identiﬁed as especially susceptible.5,6 The most
common sites of involvement in dissemination are the joints, skin,Figure 2. Hypodense intraprostatic lesion is noted on CT of the abdomen and pelvis.bones, and meninges.5 Already rare, urogenital tract involvement
most commonly involves the kidneys.4
A review of the literature reveals fewer than 40 case of male
non-renal genitourinary tract involvement described since 1943,
and fewer than ﬁfteen cases of prostatic involvement.4,5,7 However,
a retrospective review of 3676 prostatic pathology reports (biopsies
and surgical pathology) from two Arizona hospitals (an area of
endemic C. immitis) found that 44 cases of granulomatous Cocci-
dioides of the prostate gland were identiﬁed (an incidence of 1.2%),
suggesting that the undiagnosed rate may be higher in endemic
areas.8
Spread to the genitourinary system is believed to be hematog-
enous, though it is theoretically possible to seed disease through
asymptomatic coccidiuria that can accompany pulmonary disease.7
Coccidioides does not stain on Gram stain.7 As urine culture may
reﬂect involvement of another structure in the urinary tract,
deﬁnitive diagnosis of prostate involvement can be made only
with biopsy and pathology showing double walled coccidioidal
spherules.9 There are case reports of prostatic disease being
discovered only after TURP and tissue pathology; in these instances
it has been recommended to assume that disease has been seeded
throughout the body. Needle biopsy of the prostrate appears to
have a much lower risk of seeding.9
Conclusion
The patient was closely monitored in the ICU for 2 weeks. A
follow up CT scan showed resolution of the abscess, which corre-
sponded to downtrending serum creatinine values. After symp-
tomatic improvement, he was transferred to the medicine wards.
The course of amphotericin B was completed, and with his symp-
toms resolved, the patient was discharged.
Though rare, the Coccidioides should be included in the differ-
ential for immunocompromised patients presenting with prosta-
titis who have spent time in endemic areas.8 Urinalysis covering
Coccidioides is warranted as a ﬁrst step; any patient with suspected
or conﬁrmed prostatic coccidioidomycosis should undergo a full
work up and be referred to an infectious disease specialist.9 Biopsy
of the prostate may ultimately be the only method of diagnosis.
Due to the rarity of coccidioidomycosis of the prostate, speciﬁc
guidelines do not exist for treatment. Infectious Diseases Society of
American guidelines for disseminated disease recommend at least
400 mg daily of one of the eazole antifungals (ketoconazole, ﬂu-
conazole, itraconazole).10 These drugs have in limited studies
shown to reach levels in prostatic secretions equal to or nearly
equal to serum levels.5 Amphotericin B is recommended for rapidly
progressing disease.7 In the limited number of reported cases, both
amphotericin and azole-treated patients have been shown to be
able to make successful recoveries, though the period of treatment
required to drop their antibody titers to within normal limits has
varied from days to more than a year.5,9
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